At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
DRTS Alpha Tau Medical
Closed Independence Day 07-02 16:00:00 EDT
13.23
+0.59
+4.67%
盘后13.40
+0.17+1.28%
19:59 EDT
High13.23Low12.39Vol1.15M
Open12.85D1 Closing12.64Amplitude6.65%
Mkt Cap1.16BTradable Cap758.78MTotal Shares88.01M
T/O14.90MT/O Rate2.01%Tradable Shares57.35M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Alpha Tau Medical CFO Raphi Levy Disposes of 2,127 Common Shares Worth $27,691.2
Reuters  ·  07-02 23:46
Alpha Tau Medical CFO Raphi Levy Disposes of 2,127 Common Shares Worth $27,691.2
Major Insider Move at Alpha Tau Medical Ltd Shakes Up Investor Watchlists
TIPRANKS  ·  07-02 10:05
Major Insider Move at Alpha Tau Medical Ltd Shakes Up Investor Watchlists
Alpha Tau Medical CFO Raphi Levy Reports Open Market Sale of 20,000 Ordinary Shares on June 30 at $12/share - SEC Filing
THOMSON REUTERS  ·  07-01 20:24
Alpha Tau Medical CFO Raphi Levy Reports Open Market Sale of 20,000 Ordinary Shares on June 30 at $12/share - SEC Filing
Alpha Tau Medical CFO Raphi Levy Sells 20,000 Shares for $240,044
Reuters  ·  07-01 20:22
Alpha Tau Medical CFO Raphi Levy Sells 20,000 Shares for $240,044
Major Insider Move at Alpha Tau Medical Shakes Up Investor Buzz
TIPRANKS  ·  06-27
Major Insider Move at Alpha Tau Medical Shakes Up Investor Buzz
CFO’s Surprise Stock Move at Alpha Tau Medical Shakes Up Investor Buzz
TIPRANKS  ·  06-26
CFO’s Surprise Stock Move at Alpha Tau Medical Shakes Up Investor Buzz
Alpha Tau Medical Shareholders Back Board, CEO Dual Role and Auditor at June 2026 AGM
TIPRANKS  ·  06-26
Alpha Tau Medical Shareholders Back Board, CEO Dual Role and Auditor at June 2026 AGM
Alpha Tau Medical Shareholders Approve CEO Sofer to Remain Board Chair
Reuters  ·  06-26
Alpha Tau Medical Shareholders Approve CEO Sofer to Remain Board Chair
Alpha Tau Medical CFO Raphi Levy Disposes of 17,500 Common Shares Valued at $167,055.5
Reuters  ·  06-25
Alpha Tau Medical CFO Raphi Levy Disposes of 17,500 Common Shares Valued at $167,055.5
Alpha Tau Medical Continues Its Winning Streak with First-Ever Brain-Cancer Patient Treated Outside the U.S.
TIPRANKS  ·  06-24
Alpha Tau Medical Continues Its Winning Streak with First-Ever Brain-Cancer Patient Treated Outside the U.S.
Alpha Tau treats first recurrent glioblastoma patient in Israel with Alpha DaRT under broad-access study
Reuters  ·  06-23
Alpha Tau treats first recurrent glioblastoma patient in Israel with Alpha DaRT under broad-access study
Wall Street Analysts Are Bullish on Top Healthcare Picks
TIPRANKS  ·  06-13
Wall Street Analysts Are Bullish on Top Healthcare Picks
Alpha Tau Medical Says FDA Clears Additional Patients, Sites for Alpha DaRT Trial in Glioblastoma
MT Newswires Live  ·  06-11
Alpha Tau Medical Says FDA Clears Additional Patients, Sites for Alpha DaRT Trial in Glioblastoma
Alpha Tau Receives FDA Clearance to Complete Enrollment in Regain Recurrent Glioblastoma Trial and Add Two U.S. Clinical Sites; Early Interim Results Showed 100% Local Disease Control
THOMSON REUTERS  ·  06-11
Alpha Tau Receives FDA Clearance to Complete Enrollment in Regain Recurrent Glioblastoma Trial and Add Two U.S. Clinical Sites; Early Interim Results Showed 100% Local Disease Control
Alpha Tau Medical - to Resume Recruitment for Remaining Seven Patients in Regain Trial
THOMSON REUTERS  ·  06-11
Alpha Tau Medical - to Resume Recruitment for Remaining Seven Patients in Regain Trial
Alpha Tau Medical - FDA Authorizes Two Additional U.S. Cancer Centers to Join Regain Trial
THOMSON REUTERS  ·  06-11
Alpha Tau Medical - FDA Authorizes Two Additional U.S. Cancer Centers to Join Regain Trial
Top Executive Makes Major Move With Alpha Tau Medical Stock
TIPRANKS  ·  06-05
Top Executive Makes Major Move With Alpha Tau Medical Stock
Alpha Tau Medical CFO Raphi Levy disposes of $352,606 in common shares
Reuters  ·  06-05
Alpha Tau Medical CFO Raphi Levy disposes of $352,606 in common shares
Alpha Tau Medical Price Target Maintained With a $15.00/Share by HC Wainwright & Co.
Dow Jones  ·  06-04
Alpha Tau Medical Price Target Maintained With a $15.00/Share by HC Wainwright & Co.
Alpha Tau Medical Is Maintained at Overweight by Barclays
Dow Jones  ·  06-04
Alpha Tau Medical Is Maintained at Overweight by Barclays

Introduction

Company Name.
Alpha Tau Medical
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. Alpha Tau Medical Ltd. was incorporated in 2015 and is headquartered in Jerusalem, Israel.
Issue price:
--